Figure 1 (Otarmeni 01)
Otarmeni Injection, Solution
Product Images NDC 61755-062
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Otarmeni (NDC 61755-062). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Regeneron Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Otarmeni 02)
This text discusses a suspension related to a needle with the bevel pointing downward. This information might be related to medical procedures or industrial use of needles.*
Figure 2 (Otarmeni 03)
This text provides information about the size of fenestrations, which range from 0.5 to 1.0 mm. Fenestrations are openings or windows in a structure, usually referring to architectural design or biological systems. This specification can be useful for architects, engineers, or researchers working on projects where fenestration size is a critical factor.*
Figure 3 (Otarmeni 04)
This text describes the importance of a tight fit of a catheter to the round window membrane. It likely pertains to a medical procedure or device involving the delicate and precise placement of the catheter for optimal results.*
Figure 4 (Otarmeni 05)
This text indicates the correct depth for insertion into the round window. It could be related to medical procedures or any other process that requires precise measurement for insertion.*
Principal Display Panel (0.63 mL Vial Carton Bag Label)
Description: This is a prescription drug with the National Drug Code (NDC) 61755-062-99, meant to be stored frozen at -80°C. It is a suspension for intracochlear infusion manufactured by Regeneron Pharmaceuticals, Inc. Each single-dose vial contains 0.63 mL of the drug. Unused portions should be discarded.*
Principal Display Panel (0.63 mL Vial Carton)
This text appears to be a description of a pharmaceutical product called "lunsologene parvec-cwha" for intracochlear infusion. The product is in the form of a suspension and comes in single-dose vials of 0.63mL each. It mentions the use of an Administration Kit, which is provided separately and necessary for administering the product. It is advised not to use the product if the vial is broken or damaged and to discard any unused portion. The text also includes a product code: NOC 61755-062-01.*
Principal Display Panel (0.63 mL Vial Label)
This is a description of a medication called Otarmeni, with the NDC 61755-062-00 for prescription use only. It is a suspension for intracochlear infusion, with a concentration of 3.0 x 10^5 vg/mL. Each single-dose vial contains 0.63 mL, and any unused portion should be discarded. Manufactured by Regeneron and having a U.S. License No. 1760, it is a product with lot number 0000000000 and an expiration date of YYYY-MM-DD.*
Principal Display Panel (Device Kit Carton)
This text appears to be a description of an Administration Kit for a specific medical product, likely a drug or treatment called "Otarmeni" intended for intracochlear infusion only. The kit includes items such as PrecisionGlide syringes, Plastipak syringes, catheters, and other components for administering the medication as prescribed. The text also provides cautionary instructions for storage and proper use of the kit.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
